Efficacy of an activated charcoal-simethicone combination in dyspeptic syndrome: Results of a placebo-controlled prospective study in general practice

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 6-7, 2009, Pages 478-484

  Lecuyer, M ^a   Cousin, T ^b   Monnot, M N ^b   Coffin, B ^c  

^a Centre Hospitalier de Romorantin   (France)

^b Laboratoires Grimberg   (France)

^c HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON PLUS SIMETHICONE; GASTROINTESTINAL AGENT; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISEASE; ADULT; ARTICLE; BILIARY TRACT DISEASE; BLOATING; BRONCHITIS; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; NAUSEA; NEUROLOGIC DISEASE; PAIN; PHARYNGITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE;

ADULT; ANTIDOTES; CHARCOAL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DYSPEPSIA; FAMILY PRACTICE; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIMETHICONE;

EID: 67649497486     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2008.09.021     Document Type: Article

References (15)

1. Frexinos J., Denis P., Allemand H., Allouche S., Los F., and Bonnelye G. Étude descriptive des symptômes fonctionnels digestifs dans la population générale française. Gastroenterol Clin Biol 22 (1998) 785-791
2. Tack J., Bisschops R., and Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127 (2004) 1239-1255
3. Charachon A., Etienney I., Flahault A., and Soulé J.C. La recherche d'Helicobacter pylori et l'endoscopie oesogastroduodénale sont les grands oubliés de la prise en charge initiale des patients dyspeptiques en médecine générale en France (abstract). Gastroenterol Clin Biol 26 (2002) A154
4. Moayyedi P., Soo S., Deeks J., Delaney B., Innes M., and Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) CD001960
5. Moayyedi P., Soo S., Deeks J., Delaney B., Harris A., Innes M., et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) CD002096
6. Jian R., and Coffin B. Should we take into account Helicobacter pylori infection in a patient with dyspeptic symptoms?. Gastroenterol Clin Biol 27 (2003) 432-439
7. Azpiroz F., and Malagelada J.R. Abdominal bloating. Gastroenterology 129 (2005) 1060-1078
8. Holtmann G., Gschossmann J., Mayr P., and Talley N.J. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 16 (2002) 1641-1648
9. Holtmann G., Gschossmann J., Karaus M., Fischer T., Becker B., Mayr P., et al. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther 13 (1999) 1459-1465
10. Irvine E.J., Whitehead W.E., Chey W.D., Matsueda K., Shaw M., Talley N.J., et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 130 (2006) 1538-1551
11. Spiegel B.M., Vakil N.B., and Ofman J.J. Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 122 (2002) 1270-1285
12. Tack J., Talley N.J., Camilleri M., Holtmann G., Hu P., Malagelada J.R., et al. Functional gastroduodenal disorders. Gastroenterology 130 (2006) 1466-1479
13. Talley N.J., Tack J., Ptak T., Gupta R., and Giguere M. Itopride in functional dyspepsia: results of two phase-III multicentre, randomised, double-blind, placebo-controlled trials. Gut 57 (2008) 740-746
14. Smart H.L., and Atkinson M. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis. J R Soc Med 83 (1990) 554-556
15. Ansorg R., von Recklinghausen G., and Heintschel vH. Susceptibility of Helicobacter pylori to simethicone and other non-antibiotic drugs. J Antimicrob Chemother 37 (1996) 45-52